| Literature DB >> 2943815 |
Abstract
Recombinant hepatitis B virus vaccine was used to immunise groups of healthy adults, dialysis patients, staff of dialysis units and newborn infants. Seroconversion rates, mean titres and decay curves were similar to those induced by plasma-derived vaccine, including somewhat lower responses by dialysis patients. Response to recombinant vaccine was slightly delayed compared to plasma-derived vaccine, but otherwise the recombinant vaccine promises to be at least as effective as plasma-derived vaccine.Entities:
Mesh：
Substances：
Year: 1986 PMID： 2943815 DOI： 10.1016/s0163-4453(86)92683-6
Source DB: PubMed Journal: J Infect ISSN： 0163-4453 Impact factor: 6.072